Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco Helder"'
Autor:
Arjan Vissink, K Hakki Karagozoglu, Tim Forouzanfar, Henk S Brand, Derk Hendrik Jan Jager, Marco Helder, Joseph Bot, Otto Kamp, Seunghee Cha, Gary Weisman, Imke Bartelink
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/aa58c41dc5ac4da099a88078e97d021d
Autor:
Ernst Jan Bos, Mieke Pluemeekers, Marco Helder, Nikolay Kuzmin, Koen van der Laan, Marie-Louise Groot, Gerjo van Osch, Paul van Zuijlen
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 1, p e1610 (2018)
Background:. In the human ear and nose, cartilage plays a key role in establishing its form and function. Interestingly, there is a noticeable paucity on biochemical, structural, and mechanical studies focused on facial cartilage. Such studies are ne
Externí odkaz:
https://doaj.org/article/38c27a67e909406d876052da648fa5a4
Autor:
Andrii Hresko, Roman Palyvoda, Olha Burtyn, Yurii Chepurnyi, Andrii Kopchak, Marco Helder, Tymour Forouzanfar
Publikováno v:
Hresko, A, Palyvoda, R, Burtyn, O, Chepurnyi, Y, Kopchak, A, Helder, M & Forouzanfar, T 2022, ' Recurrent Ameloblastoma : Clinical Manifestation and Disease-Free Survival Rate ', Journal of oncology, vol. 2022, 2148086 . https://doi.org/10.1155/2022/2148086
Journal of oncology, 2022:2148086. Hindawi Publishing Corporation
Hresko, A, Palyvoda, R, Burtyn, O, Chepurnyi, Y, Kopchak, A, Helder, M & Forouzanfar, T 2022, ' Recurrent Ameloblastoma : Clinical Manifestation and Disease-Free Survival Rate ', Journal of oncology, vol. 2022, 2148086, pp. 1-6 . https://doi.org/10.1155/2022/2148086
Journal of oncology, 2022:2148086, 1-6. Hindawi Publishing Corporation
Journal of oncology, 2022:2148086. Hindawi Publishing Corporation
Hresko, A, Palyvoda, R, Burtyn, O, Chepurnyi, Y, Kopchak, A, Helder, M & Forouzanfar, T 2022, ' Recurrent Ameloblastoma : Clinical Manifestation and Disease-Free Survival Rate ', Journal of oncology, vol. 2022, 2148086, pp. 1-6 . https://doi.org/10.1155/2022/2148086
Journal of oncology, 2022:2148086, 1-6. Hindawi Publishing Corporation
Objectives. Ameloblastoma is a slow-growing epithelial odontogenic neoplasm of the jaws with a high recurrence rate. The main treatment strategies for this lesion are radical or conservative surgical approaches. The aim of the present study was to an